SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS
西南肿瘤集团--临床试验
基本信息
- 批准号:6341950
- 负责人:
- 金额:$ 15.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-05-24 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastics bleomycin bone marrow transplantation brain neoplasms breast neoplasms cancer information system cancer prevention cancer registry /resource cis platinum compound clinical research clinical trials combination cancer therapy combination chemotherapy cooperative study cyclophosphamide doxorubicin drug resistance female reproductive system neoplasm fludarabine gastrointestinal neoplasms head /neck neoplasm hormone therapy human subject human therapy evaluation ifosfamide leukemia lung neoplasms lymphoma meeting /conference /symposium melanoma multiple myeloma neoplasm /cancer chemotherapy neoplasm /cancer diagnosis neoplasm /cancer epidemiology neoplasm /cancer genetics neoplasm /cancer immunotherapy neoplasm /cancer radiation therapy neoplasm /cancer surgery oncology nursing paclitaxel pancreas neoplasms pathology prognosis prostate neoplasms quality of life sarcoma tamoxifen tissue resource /registry urinary tract neoplasms women's health
项目摘要
Participation in the Southwest Oncology Group (SWOG) has been a major
part of the clinical investigative effort of the section of Hematology-
Oncology in the Department of Medicine at the University of Oklahoma
Health Sciences Center (OUHSC). This effort results in the enrollment
of a consistent number of eligible and evaluable patients into SWOG
trials. SWOG protocols at the University of Oklahoma provide the major
opportunity for Oklahoma residents to participate in large scale, well
designed clinical trials. Patients are accrued via both the parent
institution and affiliated CGOPs. Most patients in the state, including
a large number of Native Americans and rural Oklahomans, are treated by
physicians who are part of this network. Annual accrual for the entire
network has been ninety-seven patients.
We have been working to increase our involvement in the scholarly
aspects of clinical trials. At the member institution, we have focused
our efforts in five areas including breast cancer, head and neck cancer,
genitourinary cancer, lung cancer, and hematological malignancies. This
effort has resulted in the establishment of multidisciplinary programs
in these areas which has helped to facilitate identification and
enrollment of patients on SWOG protocols. In addition, it has allowed
for the development of in-house protocols which might serve as pilot
studies for future SWOG trials.
参与西南肿瘤组(SWOG)是一个主要的
血液科临床研究工作的一部分-
俄克拉荷马州大学医学系肿瘤学
健康科学中心(OUHSC)。 这一努力的结果是,
进入SWOG的合格和可评价患者数量一致
审判 俄克拉荷马州大学的SWOG协议提供了主要的
俄克拉荷马州居民有机会参与大规模的,
设计的临床试验。 患者通过父母双方累积
机构和附属CGOP。 大多数患者,包括
大量的美洲原住民和俄克拉荷马州农村人,
这些医生是这个网络的一部分。 全年应计
网络已经有97名患者。
我们一直在努力增加我们在学术领域的参与,
临床试验方面。 在成员机构,我们专注于
我们在五个领域的努力,包括乳腺癌,头颈癌,
泌尿生殖系统癌症、肺癌和血液恶性肿瘤。 这
努力的结果是建立了多学科方案
在这些领域,这有助于促进识别和
根据SWOG方案招募患者。 此外,它还允许
制定可作为试点的内部协议
未来的SWOG试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD OZER其他文献
HOWARD OZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD OZER', 18)}}的其他基金
EARLY DETECTION RESEARCH NETWORK - TISSUE COLLECTION
早期检测研究网络 - 组织收集
- 批准号:
2302065 - 财政年份:1992
- 资助金额:
$ 15.87万 - 项目类别:
EARLY DETECTION RESEARCH NETWORK - TISSUE COLLECTION
早期检测研究网络 - 组织收集
- 批准号:
2302064 - 财政年份:1992
- 资助金额:
$ 15.87万 - 项目类别:
相似海外基金
Epalrestat, an aldose reductase inhibitor, alleviates bleomycin-induced skin fibrosis in mice : drug repositioning study for human systemic sclerosis
依帕司他(一种醛糖还原酶抑制剂)可减轻博来霉素诱导的小鼠皮肤纤维化:人类系统性硬化症的药物重新定位研究
- 批准号:
20K17346 - 财政年份:2020
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapy for melanoma with the combination of bleomycin and immune checkpoint inhibitors
博来霉素和免疫检查点抑制剂联合治疗黑色素瘤
- 批准号:
19K08760 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thrombomodulin suppresses bleomycin-induced pulmonary fibrosis and develop to a new candidate for IPF treatment
血栓调节蛋白可抑制博莱霉素诱导的肺纤维化,成为 IPF 治疗的新候选药物
- 批准号:
19K08844 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A role of FcgRIIB in the development of murine bleomycin-induced fibrosis model
FcgRIIB 在小鼠博莱霉素诱导的纤维化模型发展中的作用
- 批准号:
19K17766 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis
血管内皮生长因子受体1酪氨酸激酶信号在博莱霉素诱导的肺纤维化中的作用
- 批准号:
19K09291 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of alveolar epithelial type I cells in bleomycin-induced lung injury: Characterization of fibrosis-relevant signal pathways
I 型肺泡上皮细胞在博来霉素诱导的肺损伤中的作用:纤维化相关信号通路的表征
- 批准号:
373703964 - 财政年份:2017
- 资助金额:
$ 15.87万 - 项目类别:
Research Grants
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
静脉脂肪干细胞移植对博来霉素诱导的硬皮病小鼠模型的抗炎和抗纤维化作用
- 批准号:
17K16216 - 财政年份:2017
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Changes in pulmonary endothelial cell and fibroblast properties during bleomycin-induced pulmonary fibrosis
博来霉素诱导肺纤维化过程中肺内皮细胞和成纤维细胞特性的变化
- 批准号:
17K09609 - 财政年份:2017
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Statin-polymer nanoparticles enhance the anti-inflammatory and anti-fibrotic effects of adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
他汀类聚合物纳米粒子增强博莱霉素诱导的硬皮病小鼠模型中脂肪干细胞移植的抗炎和抗纤维化作用
- 批准号:
17K15761 - 财政年份:2017
- 资助金额:
$ 15.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effect of function-blocking RHAMM peptides on adipogenesis in a bleomycin-induced scleroderma mouse model
功能阻断 RHAMM 肽对博莱霉素诱导的硬皮病小鼠模型脂肪生成的影响
- 批准号:
367375 - 财政年份:2016
- 资助金额:
$ 15.87万 - 项目类别:
Studentship Programs